These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25342118)

  • 21. High prevalence of multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3.
    Gupta R; Sarna M; Thanvi J; Rastogi P; Kaul V; Gupta VP
    Indian Heart J; 2004; 56(6):646-52. PubMed ID: 15751521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behçet's disease and pregnancy.
    Noel N; Wechsler B; Nizard J; Costedoat-Chalumeau N; Boutin du LT; Dommergues M; Vauthier-Brouzes D; Cacoub P; Saadoun D
    Arthritis Rheum; 2013 Sep; 65(9):2450-6. PubMed ID: 23780828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary artery disease and its risk factors in patients presenting for liver transplantation.
    Gologorsky E; Pretto EA; Fukazawa K
    J Clin Anesth; 2013 Dec; 25(8):618-23. PubMed ID: 23994032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Headache in Behçet's disease: case-control study and literature review].
    Volpinari S; Monaldini C; Capone JG; Lo Monaco A; La Corte R; Trotta F; Govoni M
    Reumatismo; 2009; 61(3):174-81. PubMed ID: 19888502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and determinants of coronary artery disease in males and females with familial combined hyperlipidaemia.
    Pitsavos C; Skoumas I; Masoura C; Aznaouridis K; Papadimitriou L; Chrysohoou C; Giotsas N; Toutouza M; Stefanadis C
    Atherosclerosis; 2008 Aug; 199(2):402-7. PubMed ID: 18164018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura.
    Balasubramaniyam N; Kolte D; Palaniswamy C; Yalamanchili K; Aronow WS; McClung JA; Khera S; Sule S; Peterson SJ; Frishman WH
    Am J Med; 2013 Nov; 126(11):1016.e1-7. PubMed ID: 23993262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension.
    Shimony A; Eisenberg MJ; Rudski LG; Schlesinger R; Afilalo J; Joyal D; Dragatakis L; Hirsch A; Boutet K; Fox BD; Langleben D
    Am J Cardiol; 2011 Aug; 108(3):460-4. PubMed ID: 21600533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery disease in young women and men with long-standing insulin-dependent diabetes.
    Dickinson S; Rogers T; Kasiske B; Bertog S; Tadros G; Malik J; Wilson R; Panetta C
    Angiology; 2008; 59(1):9-15. PubMed ID: 18319217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative.
    Patel MR; Chen AY; Peterson ED; Newby LK; Pollack CV; Brindis RG; Gibson CM; Kleiman NS; Saucedo JF; Bhatt DL; Gibler WB; Ohman EM; Harrington RA; Roe MT
    Am Heart J; 2006 Oct; 152(4):641-7. PubMed ID: 16996828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiologic and clinical aspects of Behçet's disease in a defined area of Northwestern Spain, 1988-1997.
    González-Gay MA; García-Porrúa C; Brañas F; López-Lázaro L; Olivieri I
    J Rheumatol; 2000 Mar; 27(3):703-7. PubMed ID: 10743812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence and characteristics of different types of headache in patients with Behçet's disease, a case-control study.
    Borhani Haghighi A; Aflaki E; Ketabchi L
    Headache; 2008 Mar; 48(3):424-9. PubMed ID: 18205799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration.
    Mahr A; Belarbi L; Wechsler B; Jeanneret D; Dhote R; Fain O; Lhote F; Ramanoelina J; Coste J; Guillevin L
    Arthritis Rheum; 2008 Dec; 58(12):3951-9. PubMed ID: 19035493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behçet's disease and pregnancy: a retrospective analysis of course of disease and pregnancy outcome.
    Iskender C; Yasar O; Kaymak O; Yaman ST; Uygur D; Danisman N
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1598-602. PubMed ID: 24888922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of type D personality with unhealthy lifestyle, and estimated risk of coronary events in the general Icelandic population.
    Svansdottir E; Denollet J; Thorsson B; Gudnason T; Halldorsdottir S; Gudnason V; van den Broek KC; Karlsson HD
    Eur J Prev Cardiol; 2013 Apr; 20(2):322-30. PubMed ID: 22383854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease.
    Przewłocki T; Kabłak-Ziembicka A; Kozanecki A; Rzeźnik D; Pieniazek P; Musiałek P; Piskorz A; Sokołowski A; Rosławiecka A; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):978-84. PubMed ID: 19784902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the metabolic syndrome and newly diagnosed coronary artery disease.
    Baltali M; Gokcel A; Kiziltan HT; Korkmaz ME; Topcu S; Yalcin F; Demircan S; Yigit F; Ozin B; Muderrisoglu IH
    Diabetes Nutr Metab; 2003 Jun; 16(3):169-75. PubMed ID: 14635734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal trends (over 30 years), clinical characteristics, outcomes, and gender in patients ≤50 years of age having percutaneous coronary intervention.
    Khawaja FJ; Rihal CS; Lennon RJ; Holmes DR; Prasad A
    Am J Cardiol; 2011 Mar; 107(5):668-74. PubMed ID: 21247541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender and geographic differences in CAD risk factors and CHADS2 scores in atrial fibrillation patients.
    Bhardwaj R; Sharma P; Finkel MS; Jain S; Arham A; Kazmi T; Beto RJ; Gharib W; Warden BE; Jain AC
    W V Med J; 2012; 108(1):18-21. PubMed ID: 25134188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.